245 related articles for article (PubMed ID: 9244925)
21. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
23. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
[TBL] [Abstract][Full Text] [Related]
24. [5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer].
Faivre C; Rougier P; Ducreux M; Mitry E; Lusinchi A; Lasser P; Elias D; Eschwege F
Bull Cancer; 1999 Oct; 86(10):861-5. PubMed ID: 10572237
[TBL] [Abstract][Full Text] [Related]
25. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
[TBL] [Abstract][Full Text] [Related]
26. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
27. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
28. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
29. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
[TBL] [Abstract][Full Text] [Related]
30. The role of radiation therapy after incomplete resection of penile cancer.
Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
[TBL] [Abstract][Full Text] [Related]
31. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
32. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients].
Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T
Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma of the anus treated with primary radiation therapy and chemotherapy.
Johnson D; Lipsett J; Leong L; Wagman LD; Terz JJ
Surg Gynecol Obstet; 1993 Oct; 177(4):329-34. PubMed ID: 8211574
[TBL] [Abstract][Full Text] [Related]
34. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
Chauveinc L; Buthaud X; Falcou MC; Mosseri V; De la Rochefordière A; Pierga JY; Girodet J; Salmon RJ
Br J Cancer; 2003 Dec; 89(11):2057-61. PubMed ID: 14647138
[TBL] [Abstract][Full Text] [Related]
35. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
[TBL] [Abstract][Full Text] [Related]
36. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma.
Raffetto N; Monaco A; Banelli E
Anticancer Res; 2008; 28(2B):1335-9. PubMed ID: 18505075
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
39. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
40. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
Nakamura RA; Novaes PE; Antoneli CB; Fogaroli RC; Pellizzon AC; Ferrigno R; Maia MA; Salvajoli JV; Pereira AJ; Nishimoto IN
Cancer; 2005 Aug; 104(3):525-31. PubMed ID: 15986481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
